NCT Number: NCT04109729
Phase: Phase 1|Phase 2
Trial Summary: This is an open label, prospective, trial that begins with a phase Ib safety run-in followed by a ph – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of Utah
Acronym: Rad2Nivo
Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives